ABBV vs BMYMP: Valuation Comparison 2026

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Side-by-side fundamentals for AbbVie Inc. (ABBV) and Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) — market cap, PE, PEG and sector. All figures from SEC filings and market data.

AbbVie Inc.

ABBV

Healthcare

Full ABBV valuation →

Bristol-Myers Squibb Company PFD CONV 2

BMYMP

Healthcare

Full BMYMP valuation →
MetricABBVBMYMP
SectorHealthcareHealthcare
IndustryBiotechnologyDrug Manufacturers - General
Current Price (Cboe, delayed)$263.96$400
Market Cap$466.45B$814.59B
PE Ratio74.3587.91
PEG Ratio—16.51
PEG VerdictN/APEG above 2.0
ABBV fair valueBMYMP fair valueABBV supply chainBMYMP supply chain

More comparisons

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.